Detection of Specific Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein for Serodiagnosis of SARS Coronavirus Pneumonia

Documenti analoghi

• Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia
  di: Woo, Patrick C. Y., et al.
  Pubblicazione: (2005)
• Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent Assay
  di: Lau, Susanna K. P., et al.
  Pubblicazione: (2004)
• Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS Coronavirus
  di: Woo, Patrick C. Y., et al.
  Pubblicazione: (2004)
• False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide
  di: Woo, Patrick C. Y., et al.
  Pubblicazione: (2004)
• Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia
  di: Woo, Patrick CY, et al.
  Pubblicazione: (2004)